What is the issue size of Saakshi Medtech IPO?

The issue size of the Saakshi Medtech IPO is Rs 45.16 cr

What is 'pre-apply' for Saakshi Medtech IPO?

Pre-apply will alow you to apply for the Saakshi Medtech IPO 2 days before the subscription period starts.

If I pre-apply for Saakshi Medtech IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Saakshi Medtech IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Saakshi Medtech IPO order is placed?

We will notify you when your Saakshi Medtech IPO order is placed with the exchange.

What are the open and close dates of the for Saakshi Medtech IPO?

Saakshi Medtech IPO will be open between 25 Sept - 27 Sept, 2023.

What is the lot size and minimum order quantity of the Saakshi Medtech IPO?

Saakshi Medtech Limited IPO lot size is 1200 shares.

What are the allotment dates for the Saakshi Medtech IPO?

Saakshi Medtech IPO allotment date is 3 Oct, 2023. For Saakshi Medtech IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Saakshi Medtech IPO?

Saakshi Medtech IPO registrar is Bigshare Services Pvt Ltd. You can check Saakshi Medtech IPO allotment status on the website of the registrar.

Where is the Saakshi Medtech IPO getting listed?

The shares are proposed to be listed on NSE SME.

Saakshi Medtech IPO

Saakshi Medtech Limited

₹1,10,400 /1200 sharesMinimum Investment

Saakshi Medtech IPO Listing DetailsListed OnIssue PriceListing PriceListing Gains
NSE₹97.00₹146.00₹49.00 (50.52%)
Saakshi Medtech IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
25 Sep ‘23 - 27 Sep ‘23₹1,10,4001,200₹92 - ₹97
Issue SizeIPO Doc
45.16CrRHP PDF
About Saakshi MedtechIncorporated in 2009, Saakshi Medtech is a diversified company engaged in various manufacturing activities. They produce electrical control panels and cabinets used in elevators, air compressors, renewable energy, oil & gas exploration, and electric vehicle charging stations. They manufacture medical X-ray systems for the healthcare industry, offer fabrication services for locomotives, operate a wire harness division for internal electrical control panel needs, and supply the air compressor industry. They have experience in product prototype design, development, functional testing, validation, and verification.
With its in-house engineering and design capabilities, Saakshi Medtech provides diverse products and solutions across these categories. Their comprehensive solutions encompass design, process engineering, and manufacturing, including fabrication, assembly, and testing. ;
Parent Organisation
Saakshi Medtech Limited
Founded
2009
Managing Director
Mr. Aniket Vijay Latkar
Strengths & Risks
Since 2018, the company has been certified as a manufacturer of medical diagnostic X-ray equipment by AERB. They also obtained a license to manufacture medical devices for testing from The Central Drugs Standard Control Organisation (CDSCO). 
The company's testing lab is now NABL-certified for medical diagnostic X-ray equipment testing.
The company has garnered certificates for its fabrication work in compliance with EN Standards and is recognized as a welding workshop that meets the standard requirements. 
Their electrical control panels have CE certification, ensuring product quality and safety. For international export orders of medical X-ray systems, they conduct tests in accordance with IEC standards, facilitating distribution and use in multiple countries.
The company's revenue from operations increased at a CAGR of 42.90% from Rs. 5,977.39 lakhs in 2021 to Rs. 12,205.82 lakhs in 2023. They have also seen profit growth, rising from Rs. 220.08 lakhs in 2021 to Rs. 1,238.30 lakhs in 2023.
Saakshi Medtech relies heavily on key customers for selling its products. In 2023, 2022, and 2021, the top five customers accounted for 93.08%, 90.45%, and 90.57% of their revenue from operations, respectively. The potential loss of these customers or a decrease in revenue from them could significantly impact the company's business and cash flow.
The company's primary revenue source comes from the sale of electrical control panels and cabinets. Any failure to predict or adapt to changes in product requirements, maintain product quality, or reduce demand for these items may adversely affect their revenue and growth. 
The company faces potential disruptions due to delays, interruptions, or reductions in the supply of raw materials needed for manufacturing. Key components like weld nuts, bolts, rivets, washers, conduits, hose clamps, gaskets, etc., are imported from countries like the USA, China, and Germany. 
The company's manufacturing facilities, factory units I and II, operate on leased premises from the Maharashtra Industrial Development Corporation, and their lease agreements may not be renewed upon expiration.
The company's expansion plans for factory unit III are subject to potential delays, uncertainties, and cost overruns.
The company primarily manufactures and sells its products in India, serving multinational customers with global headquarters in North America and Europe. Their operations are exposed to country-specific risks based on their customer locations.
The company is involved in legal proceedings and potential litigations, and an adverse decision in these cases could result in liabilities, penalties, or prosecutions, adversely affecting their business.
The company has availed unsecured loans, including Rs. 33.47 lakhs as of March 31, 2023, which lenders may call at any time.
As of March 31, 2023, the company had contingent liabilities totaling Rs. 581.94 Lakhs, and if these liabilities materialize partially or fully, it could impact the company's financial condition.
The company faces foreign currency fluctuation risks due to importing certain raw materials and components, which may affect its operational results.
Financials
*All values are in Rs. Cr
No Graph Data To Display
Application detailsApply asPrice bandApply upto
Regular₹92 - 97₹2 Lakh
High Networth Individual₹92 - 97₹2 - 5 Lakh
For Saakshi Medtech IPO, eligible investors can apply as Regular.

Listed On	Issue Price	Listing Price	Listing Gains
NSE	₹97.00	₹146.00	₹49.00 (50.52%)

Bidding Dates	Min. Investment	Lot Size	Price Range
25 Sep ‘23 - 27 Sep ‘23	₹1,10,400	1,200	₹92 - ₹97

Issue Size	IPO Doc
45.16Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹92 - 97	₹2 Lakh
High Networth Individual	₹92 - 97	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemap
ⓒ 2016-2023 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s growing financial services platform where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

NextBillion Technology Private Limited (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

NextBillion Technology Private Limited makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.